South Korea approves the Celltrion antibody COVID-19 treatment for infected adults in high-risk groups and adults with severe symptoms. (Reuters) COVID-19 pandemic in South Korea, COVID-19 drug developmentCOVID-19 pandemic in AsiaCOVID-19 pandemic link embed save